Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan

Por Saida, Takahiko, Yokoyama, Kazumasa, Sato, Ryusuke, Makioka, Haruki, Iizuka, Yukihiko, Hase, Masakazu, Ling, Yan, Torii, Shinichi
Publicado no Neurol Ther (2017)

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled,...

Por Ochi, Hirofumi, Niino, Masaaki, Onizuka, Yasuhiro, Hiramatsu, Katsutoshi, Hase, Masakazu, Yun, Jang, Matta, André, Torii, Shinichi
Publicado no Adv Ther (2018)

Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial

Por Saida, Takahiko, Kira, Jun-Ichi, Kishida, Shuji, Yamamura, Takashi, Ohtsuka, Nobuhisa, Ling, Yan, Torii, Shinichi, Lucas, Nisha, Kuesters, Geoffrey, Steiner, Deb, Tibung, J. T.
Publicado no Neurol Ther (2016)